Local scientific software firm plans to add 63 jobs
Indianapolis-based Indigo Biosystems Inc., a scientific software provider, announced Monday morning that it plans to add 63 jobs by 2015 as part of a $1.4 million expansion.
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Company news
Indianapolis-based Indigo Biosystems Inc., a scientific software provider, plans to add 63 jobs by 2015 as part of a $1.4 million expansion. The company, headquartered at 20 E. 91st St. in Woodland Corporate Park IV, now has about 30 employees and is hiring engineers, mathematicians, scientists and project managers. Using advanced algorithms, Indigo’s cloud-based software enables analytical laboratories to automate diagnostic tests performed on millions of patient samples every year. The company was founded in 2004 by Dr. Randall K. Julian Jr. as a project of the Lilly Ventures arm of drugmaker Eli Lilly and Co. Indigo became an independent company in 2008.
Health officials developing a statewide trauma system say Indiana needs more than the eight trauma centers it currently has, according to the Associated Press. The State Department of Health trauma prevention experts say only 58 percent of Indiana residents live within 45 minutes of one of Indiana's eight trauma centers certified by the American College of Surgeons. Three are in Indianapolis—at Wishard Memorial Hospital, Indiana University Health's Methodist Hospital and St. Vincent Indianapolis Hospital. There are also two each in Fort Wayne and Evansville and one in South Bend. Traumatic injuries are the top killer of Hoosiers under age 45, and injuries hospitalize more than 32,000 people each year. About 3,700 injuries resulted in death in 2009, the most recent data available.
The Indianapolis-based Regenstrief Institute has signed a five-year agreement with New Jersey-based drugmaker Merck & Co. Inc. to explore new methods for studying diseases and interventions for chronic conditions such as diabetes, cardiovascular disease and osteoporosis. Financial details of the collaboration were not disclosed. “With Merck’s depth of expertise and its global reach, we hope to develop and test new approaches to care, and advance successful models of health care broadly,” said Dr. Jon Duke, Regenstrief’s innovations officer. The two organizations think their work can improve drug development and the safety of medicines, as well as advance the personalization of medical treatments.
Drugmakers collaborate to facilitate drug tests
Eli Lilly and Co. and two other major drugmakers say they are collaborating in a global project aimed at getting patient tests of experimental drugs up and running more quickly and efficiently.
Plenty of turbulence ahead, despite Republic’s progress
Analysts are impressed by Bedford’s cost-cutting achievements at Republic’s scheduled-service carrier, Frontier Airlines, and his early progress in restructuring its Chautauqua unit, which flies small regional jets on contract for branded carriers.
Lilly donating $12.4 million to United Way
Eli Lilly and Co. said Monday it plans to give $12.4 million to the United Way, the largest single charitable donation in the company’s history.
Speedway, IndyCar owner names Miles as new CEO
Hulman & Co., which owns Indianapolis Motor Speedway and the IndyCar series, has chosen board member and local economic development leader Mark Miles as its new CEO, the firm announced Tuesday morning.
MAURER: Endocyte receded, but it’s still on track
Endocyte is an Indiana biopharmaceutical company that develops drugs and imaging diagnostics to identify and treat cancer.
Company news
NoviaCare Clinics LLC, which operates on-site clinics for employers, is gradually pitching a new constellation of services, which it calls Total Patient Experience, to its 85 clients. The effort is one of a few initiatives to get employers to push deeper to address the causes of their workers’ health problems. Indianapolis-based NoviaCare is negotiating contracts with financial counselors, substance abuse counselors, mental health counselors and physical therapists who can be called in to its employer clinics to help address the underlying causes of patients’ health issues. So far, NoviaCare has signed up Batesville Tool & Dye and Hillenbrand Inc. to use the physical therapy portion of its service. NoviaCare hopes employers come to embrace its entire suite of services down the road.
The number of serious medical errors at hospitals and nursing homes fell to 100 last year from 107 in 2010, according to the Indiana State Health Department's 2011 Medical Errors report. According to a report by WTHR-TV Channel 13, the most common errors were severe bed sores, followed by surgery on the wrong body part, and foreign objects left after surgery. Indiana University Health’s three downtown hospitals reported 14 errors, the highest number in the state. But those hospitals also see more patients than any other in the report. Nearly a third of the state's hospitals reported at least one error.
Eli Lilly and Co. gave $12.4 million to the United Way, a slight uptick from its United Way gift from last year. The donation represents the contributions of Lilly’s U.S. employees and retirees, plus a matching gift from the Eli Lilly and Company Foundation. The funds will help support the United Way of Central Indiana as well as other local United Way chapters around the country. Also, the Lilly Foundation gave $200,000 to the American Red Cross to provide disaster relief to victims of superstorm Sandy.
Lilly chief says China too slow in approving new drugs
China takes eight years longer on average to approve drugs than other major countries, and U.S. drugmakers are looking at ways to help speed things up, Eli Lilly and Co. CEO John Lechleiter said.
State health commissioner returning to private sector
Dr. Gregory N. Larkin, appointed commissioner of the Indiana State Department of Health by Gov. Mitch Daniels in 2010, will leave his position in January to become medical director of OurHealth, an employer on-site clinic company.
People
State Health Commissioner Dr. Greg Larkin will become chief medical officer of Indianapolis-based OurHealth, a provider of employer on-site clinic services, after he ends his service with the state in early January. Gov. Mitch Daniels, who is leaving office in January, appointed Larkin to the position in 2010, replacing Dr. Judy Monroe. Larkin previously spent much of his career as Eli Lilly and Co.’s director of corporate health service and served as global medical director. After retiring from Lilly in 2007, Larkin served as the first chief medical officer of the Indiana Health Information Exchange, which promotes health information technology for the advancement of patient and community care.
Terri S. Ruff has been appointed executive director of Franciscan St. Francis Heart Center, starting on Jan. 6. Ruff will succeed Michael Hertel, who had led the heart center since 2006. Since 2002, Ruff has overseen all radiological programs at Franciscan St. Francis Health. Ruff holds a bachelor’s degree in health arts, a master’s degree in health care administration and an MBA from the University of St. Francis.
Indiana University Health Orthopedics and Sports Medicine named Dr. Walter Virkus as its director of orthopedic trauma services. He will be based at IU Health’s Methodist Hospital. Virkus spent the last 12 years in Chicago at Rush University Medical Center. He also served as chairman of orthopedics at the Stroger Hospital of Cook County. Virkus holds a bachelor’s degree from Muhlenberg College in Allentown, Pa., and a medical degree from the New Jersey Medical School in Newark.
Dr. Todd McKinley, an orthopedic trauma surgeon, has joined IU Health Orthopedics and Sports Medicine. Before joining IU Health, McKinley served as a professor and orthopedic surgeon for trauma services at University of Iowa Hospitals and Clinics. He earned his bachelor’s degree in aerospace engineering and mechanics from the University of Minnesota Institute of Technology and received his medical degree from the University of Minnesota Medical School.
Dr. Anthony Sorkin, an orthopedic trauma surgeon, has joined IU Health Orthopedics and Sports Medicine. Before joining IU Health, Sorkin served as director of orthopedic traumatology for Rockford Orthopedics, an orthopedic multi-specialty physician group, and as a professor at both Rush University Medical Center and the University of Illinois College of Medicine. He earned his bachelor’s degree in biology from the University of Miami and received his medical degree from the University of Maryland School of Medicine.
Dr. Michael Zlowodzki, an orthopedic trauma surgeon, has joined IU Health Orthopedics and Sports Medicine. He earned his medical degree from the University of Hamburg in Germany and his doctorate from Humboldt University in Berlin.
St. Vincent Medical Group recruited three orthopedic surgeons to provide care at Monroe Hospital in Bloomington, St. Vincent Dunn Hospital in Bedford and St. Vincent Jennings Hospital in North Vernon. The practice of Dr. Michael Ferrell, Dr. John Hammerstein and Dr. Brian Murphy will change its name from PremierOrtho to St. Vincent Medical Group Orthopedics and Sports Medicine, and will be based in Bloomington. Ferrell is a former commander in the U.S. Navy Medical Corps. He did his medical training at Virginia Commonwealth University. Hammerstein and Murphy did their medical training at the Indiana University Medical School.
Indiana Historical Society wraps up $19M campaign
The Indiana Historical Society has raised $19.5 million to support the Indiana Experience, its series of interactive history lessons intended to draw more visitors to the local not-for-profit’s downtown facility.
MAURER: Think outside the retirement box
I realized that my original vision of the American Dream was a nightmare. I learned that there is more to business than the money earned.
Lilly notifies Canada about NAFTA complaint on Strattera patent
Eli Lilly and Co. notified Canada it plans to file a trade complaint, claiming court decisions invalidating one of the company’s patents breach international obligations.
IU chemist DiMarchi receives science award from Daniels
Richard DiMarchi helped develop the sepsis-treating drug Xigris for Eli Lilly and Co. He also co-founded Marcadia Biotech, which Roche acquired in 2010 for an initial upfront payment of $287 million.
Analyst: Lilly solid even without pipeline
While Eli Lilly and Co.’s stock price is up 16 percent in the past four months, a new analyst covering the company thinks it has more room to grow. And that’s even without launching a new Alzheimer’s drug anytime soon.
Lilly plans another study for Alzheimer’s drug
Eli Lilly will launch another study of its possible Alzheimer's treatment solanezumab, a move that delays a regulatory decision on a drug that flashed potential to help patients with mild cases of the fatal disease.
